Latigo Biotherapeutics Inc.

LTGO

LTGOLatigo Biotherapeutics Inc. US flag

NASDAQ

19.84

USD

+0.54

- -

1.19BMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	63	110
+ Selling, General & Admin	7	11
+ Research & Development	57	100
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-63	-110
- Non-Operating (Income) Loss	-2	-1
+ Interest Expense, Net	-2	-3
+ Interest Expense	- -	- -
- Interest Income	2	3
+ Other Non-Op (Income) Loss	- -	2
Pretax Income	-61	-109
- Income Tax Expense (Benefit)	- -	- -
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-61	-109
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-61	-109
- Minority Interest	- -	- -
Net Income, GAAP	-61	-109
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-61	-109
EBIT	-63	-110
EBITDA	-63	-110
EBITDA Margin (%)	- -	- -
EBITA	-63	-110
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	- -	- -
Basic Weighted Avg Shares	- -	- -
Basic EPS, GAAP	- -	- -
Basic EPS from Cont Ops	- -	- -
Diluted Weighted Avg Shares	- -	- -
Diluted EPS, GAAP	- -	- -
Diluted EPS from Cont Ops	- -	- -

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	21	74
+ Cash, Cash Equivalents & STI	18	69
+ Cash & Cash Equivalents	18	69
+ ST Investments	- -	- -
+ Accounts & Notes Receiv	- -	- -
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	- -	- -
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	3	4
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	2	2
+ Property, Plant & Equip, Net	1	1
+ Property, Plant & Equip	2	2
- Accumulated Depreciation	1	1
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	- -	1
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	- -	1
Total Assets	23	76
+ Payables & Accruals	12	14
+ Accounts Payable	7	5
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	5	9
+ ST Debt	- -	1
+ ST Borrowings	- -	- -
+ ST Finance Leases	- -	1
+ Other ST Liabilities	2	4
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	2	4
Total Current Liabilities	14	18
+ LT Debt	- -	- -
+ LT Borrowings	- -	- -
+ LT Finance Leases	- -	- -
+ Other LT Liabilities	138	289
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	138	289
Total Noncurrent Liabilities	138	289
Total Liabilities	152	307
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	4	11
+ Common Stock	- -	- -
+ Additional Paid in Capital	4	11
- Treasury Stock	- -	- -
+ Retained Earnings	-134	-243
+ Other Equity	- -	- -
Equity Before Minority Interest	-130	-232
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-130	-232
Total Liabilities & Equity	23	76
Shares Outstanding	- -	- -
Number of Employees	- -	- -
Capital Leases - Total	1	1
Net Debt	-18	-69
Net Debt to Equity	13.83	29.97
Tangible Common Equity Ratio	-566.83	-306.79
Current Ratio	1.47	4
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-61	-109
+ Depreciation & Amortization	- -	- -
+ Non-Cash Items	3	9
+ Stock-Based Compensation	3	7
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	- -	2
+ Chg in Non-Cash Work Cap	7	3
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	-2	-1
+ Inc (Dec) in Accts Payable	9	4
+ Inc (Dec) in Other	- -	-1
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-51	-98
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	- -	- -
+ Acq of Fixed Prod Assets	- -	- -
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	- -	- -
+ Dec in LT Investment	- -	- -
+ Inc in LT Investment	- -	- -
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	- -	- -
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	- -	149
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	1	149
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	-50	52
EBITDA	-63	-110
EBITDA Margin (%)	- -	- -
Free Cash Flow	-51	-98
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-98
Free Cash Flow per Basic Share	- -	- -
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	0.83	0.89
Capital Expenditures	- -	- -